2017 NCCN Oncology Case Manager and Medical Director Program™ Live Webinars

The NCCN 2017 Case Manager and Medical Director Program consists of six live webinars focused on the needs of case managers, medical directors, nurses and other health care professionals who interact with patients with cancer.

Target Audience

This program is designed to meet the educational needs of case managers, nurses in other roles (i.e., quality management and utilization review), medical directors at managed care organizations, reinsurers, TPAs, and case management and disease management companies who interact with, counsel, and refer patients with cancer to appropriate sources of care and/or make coverage decisions. Programs may also be of interest to nurses, nurse navigators/care coordinators, and physicians who work directly with patients in clinical settings as well as clinical pharmacists in managed care organizations and other settings.

Learning Objectives

Following this program, participants should be able to:

Cancer 101

  • Educate patients and their caregivers on the basics of cancer and key concepts about cancer care.
  • Help patients identify the members of their multidisciplinary care team and each member’s role in cancer management.
  • Discuss the relevance of recent advances with patients and caregivers and encourage enrollment in clinical trials.

Updates in the Diagnosis and Treatment of B-cell Non-Hodgkin’s Lymphoma

  • Identify the challenges involved in the diagnosis and management of patients with B-cell NHLs.
  • Summarize the recommendations outlined in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) B-Cell Lymphoma Guidelines for the management of various subtypes of B-cell NHL.
  • Review the treatment-related toxicities and develop an effective supportive care plan to monitor and manage potential side effects in patients with B-cell NHLs.

Updates in the Diagnosis and Treatment of Colon Cancer

  • Provide an overview of the therapeutic options for patients with colon cancer.
  • Describe important disease and patient characteristics used to inform treatment decisions in patients with colon cancer.
  • Discuss survivorship care as it applies to those treated for colon cancer.

Updates in the Diagnosis and Treatment of Lung Cancer

  • Educate patients by providing a broad overview of lung cancer.
  • Discuss appropriate biomarker tests for patients with non-small cell lung cancer (NSCLC).
  • Describe the different types of immunotherapy and targeted therapy for patients with metastatic NSCLC.

Updates in the Management of Breast Cancer

  • Provide caregivers and patients with localized breast cancer information about all available treatment options and discuss benefits versus harms for informed shared-decision making.
  • Explain the role of available genomic assays in decision-making regarding adjuvant chemotherapy and extended adjuvant endocrine therapy.
  • Describe the advances in systemic therapy options for patients with advanced breast cancer.

Transitioning from Patient with Cancer to Cancer Survivor

  • Describe common challenges patients face during the transition from active cancer treatment to survivorship.
  • Explain the potential role of survivorship care plans in optimizing the transition to the survivorship phase.
  • Discuss additional ways to facilitate a smooth transition for survivors after active cancer treatment.
Additional information
Supporters: 

This activity is supported by educational grants from Astellas and Medivation, Inc., a Pfizer Company; AstraZeneca; Genentech; Genomic Health, Inc.; Olympus Corporation of the Americas; Taiho Oncology; and Takeda Oncology. This activity is supported by independent educational grants from AbbVie and Boehringer Ingelheim Pharmaceuticals, Inc.

 

 

Additional Resources for Patient and Payment Assistance

The oncology reimbursement landscape continues to present ever-evolving challenges for clinicians and others that work with patients with cancer. As a response to these ongoing challenges, help is available through the NCCN Virtual Reimbursement Resource Room.

Course summary
Course opens: 
08/09/2017
Course expires: 
12/15/2017
Cost:
$0.00

Recorded presentations are now available for the following sessions:

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Physicians
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NCCN designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 7.5 hours of Category I credits for completing this activity.

Nurses
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NCCN designates this educational activity for a maximum of 7.5 contact hours.

Case Managers
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. This course is approved for 7.5 CE contact hours.

Cancer 101
Monday, September 25, 2017 • 12:00 - 1:15 PM EDT
1.25 CE contact hours
Activity Code: I00028520; Approval Number: 170003528

Updates in the Diagnosis and Treatment of B-cell Non-Hodgkin’s Lymphoma
Monday, October 23, 2017 • 12:00 - 1:15 PM EDT
1.25 CE contact hours
Activity Code: I00028892; Approval Number: 170003898

Updates in the Diagnosis and Treatment of Colon Cancer
Wednesday, November 1, 2017 • 12:15 - 1:30 PM EDT
1.25 CE contact hours
Activity Code: I00028894; Approval Number: 170003900

Updates in the Diagnosis and Treatment of Lung Cancer
Tuesday, November 7, 2017 • 1:00 - 2:15 PM EST
1.25 CE contact hours
Activity Code: I00028896; Approval Number: 170003902

Updates in the Management of Breast Cancer
Thursday, November 30, 2017 • 12:00 - 1:15 PM EST
1.25 CE contact hours
Activity Code: I00028897; Approval Number: 170003903

Transitioning from Patient with Cancer to Cancer Survivor
Wednesday, December 13, 2017 • 12:00 - 1:15 PM EST
1.25 CE contact hours
Activity Code: I00028899; Approval Number: 170003905

Pharmacists

National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

NCCN designates this knowledge-based continuing education activity for 7.5 contact hours (0.75 CEUs) of continuing education credit.

Cancer 101
Monday, September 25, 2017 • 12:00 - 1:15 PM EDT
1.25 contact hours (0.125 CEUs)
UAN: 0836-0000-17-086-L01-P

Updates in the Diagnosis and Treatment of B-cell Non-Hodgkin’s Lymphoma
Monday, October 23, 2017 • 12:00 - 1:15 PM EDT
1.25 contact hours (0.125 CEUs)
UAN: 0836-0000-17-108-L01-P

Updates in the Diagnosis and Treatment of Colon Cancer
Wednesday, November 1, 2017 • 12:15 - 1:30 PM EDT
1.25 contact hours (0.125 CEUs)
UAN: 0836-0000-17-109-L01-P

Updates in the Diagnosis and Treatment of Lung Cancer
Tuesday, November 7, 2017 • 1:00 - 2:15 PM EST
1.25 contact hours (0.125 CEUs)
UAN: 0836-0000-17-110-L01-P

Updates in the Management of Breast Cancer
Thursday, November 30, 2017 • 12:00 - 1:15 PM EST
1.25 contact hours (0.125 CEUs)
UAN: 0836-0000-17-111-L01-P

Transitioning from Patient with Cancer to Cancer Survivor
Wednesday, December 13, 2017 • 12:00 - 1:15 PM EST
1.25 contact hours (0.125 CEUs)
UAN: 0836-0000-17-112-L01-P

 
Status
Price
Title
Locked
$0.00Included
2017 NCCN Oncology Case Manager and Medical Director Program™ Live Webinars
Please login or register to take this course.
Locked
$0.00Included
2017 NCCN Case Manager and Medical Director Program: Cancer 101
Please login or register to take this course.
Locked
$0.00Included
2017 NCCN Case Manager and Medical Director Program: Updates in the Diagnosis and Treatment of B-cell Non-Hodgkin’s Lymphoma
Please login or register to take this course.
Locked
$0.00Included
2017 NCCN Case Manager and Medical Director Program: Updates in the Diagnosis and Treatment of Colon Cancer
Please login or register to take this course.
Locked
$0.00Included
2017 NCCN Case Manager and Medical Director Program: Updates in the Diagnosis and Treatment of Lung Cancer
Please login or register to take this course.
Locked
$0.00Included
2017 NCCN Case Manager and Medical Director Program: Updates in the Management of Breast Cancer
Please login or register to take this course.
Locked
$0.00Included
2017 NCCN Case Manager and Medical Director Program: Transitioning from Patient with Cancer to Cancer Survivor
Please login or register to take this course.

Price

Cost:
$0.00
Please login or register to take this course.

Please refer to the Schedule tab for dates and times.  Check the webinars you would like to attend and click Enroll.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing